Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

32.47
+0.24000.74%
Post-market: 32.510.0400+0.12%19:30 EDT
Volume:1.39M
Turnover:45.31M
Market Cap:19.97B
PE:25.67
High:32.70
Open:32.45
Low:32.27
Close:32.23
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:1.06
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.35
PE(LYR):21.13

Loading ...

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
May 05

Earning Preview: Genmab A/S this quarter’s revenue is expected to increase by 17.37%, and institutional views are predominantly bullish

Earnings Agent
·
May 01

Genmab A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
May 01

Genmab Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 30

Genmab price target lowered to $38 from $40 at H.C. Wainwright

TIPRANKS
·
Apr 30

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 30

Genmab: Buy Rating Backed by Expanded Petosemtamab-Keytruda Phase III Trial and Blockbuster Late-Stage Pipeline

TIPRANKS
·
Apr 28

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Apr 28

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Apr 25

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Apr 23

Goldman Sachs Upgrades Genmab to Buy From Neutral, Adjusts Price Target to $30.50 From $24.50

MT Newswires Live
·
Apr 22

Genmab upgraded to Outperform from Neutral at BNP Paribas

TIPRANKS
·
Apr 22

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Apr 21

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Apr 18

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 16

Genmab Reports Q1 Net Sales of DARZALEX

MT Newswires Live
·
Apr 14

Genmab reports Darzalex Q1 worldwide sales $3.964B

TIPRANKS
·
Apr 14

Genmab A/S Stock Rises Monday

Dow Jones
·
Apr 14

Genmab Says Rinatabart Sesutecan Combination Tolerable in Patients With Advanced Ovarian Cancer

MT Newswires Live
·
Apr 13

Genmab presents safety, tolerability data on Rina-S with bevacizumab

TIPRANKS
·
Apr 13